Union Minister of State for Health and Family Welfare Bharati Pravin Pawar on Thursday said India aims to strive for equitable access to healthcare for all
The minister also said that there is no risk of data theft in digitisation of medical records of Indian citizens
Lymphatic filariasis is not a neglected disease for India as may be the case in some other countries but is a priority for elimination in a time-bound manner, Union Health Minister Mansukh Mandaviya said Friday. Inaugurating the National Symposium on India's Roadmap to Eliminate Lymphatic Filariasis here, he reiterated India's commitment towards the target of eradicating the disease from the country by end of 2027. As part of its commitment to eliminate the disease by end of 2027, the health ministry has come up with a renewed five-pronged strategy as part of which multi-drug administration (MDA) will be held twice a year in synchronisation with National Deworming Day on February 10 and August 10, Mandaviya said. The other aspects of the strategy include early diagnosis and treatment; engagement of medical colleges for strengthening morbidity management and disability services; integrated vector control with multi-sectoral coordinated efforts; inter-sectoral convergence with allied
The Kerala government has granted an additional Rs 200 crore for Karunya Arogya Suraksha Padhathi (KASAP), its integrated health protection scheme that is estimated to have benefited 64 lakh people in the southern state. With this additional allocation, the total amount granted for the flagship scheme in the present financial year has gone up to Rs 800 crore, state Finance Minister K N Balagopal said in a statement. He said KASAP is a comprehensive scheme which ensures the healthcare of 42 lakh families in Kerala and the State Health Agency under the Health Department, is implementing the programme. "The scheme has been launched by the state government with an objective of avoiding a situation where sudden heavy medical expenses push ordinary families into financial ruin," the minister said. Giving details of the healthcare scheme, he said an average of 180 patients per hour (3 patients per 1 minute) benefit from it. At present, 1,667 treatment packages are included as part of th
Investment activity in the health care space has not slowed down due to the Covid-19 pandemic
Will start rebranding Fortis as Parkway shortly: Fortis chairman Ravi Rajagopal
The Parliamentary Standing Committee on Health and Family Welfare has recommended setting up of a new set of regulators at different levels for regulating the medical Devices industry
The growth in Q2FY23 revenue and operating EBITDA were driven by higher occupancies, improved payor mix, and increased ARR in OPD.
He further added that under PM Modi's leadership healthcare has become more focused on innovation and technology over the past few years
13 XBB variants detected in Maharashtra are all under home-isolation; the strain spreads rapidly and is said to be behind the recent spike in Singapore
Hyderabad-based company will use financing to introduce more product categories and expand team
Completes phase 2 trials successfully on 200 patients
On August 1 this year, Bubber Jindal and Company tendered its resignation as statutory auditor of SpiceHealth
The government is considering changing the definition of "death" in the law on organ transplants
Besides health, trade and IT/BPO sectors saw vacancies increasing during the pandemic's Omicron phase
First major acquisition by Aman Mehta after taking charge at Torrent Pharma in August
Taking legal advice on next steps to pursue open offer for 26% stake in Fortis
The Nifty Pharma index finished at 12,750, up 3.1 per cent - most since May 20 and third biggest single-day gain of the year
Of the 1.3 million active patients in India, around 890,000 have given consent to be up for adoption
The Drugs Controller General of India (DCGI), on Tuesday, approved Bharat Biotech's anti-covid vaccine for emergency use. It is the first such vaccine in the country